Rafael Holdings Inc (RFL) FinancialsRFLRafael Holdings Inc

Rafael Holdings Inc (RFL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Healthcare, accounting for 59.2% of total sales, equivalent to $125.00K. Another important revenue stream is Real Estate. Understanding this composition is critical for investors evaluating how RFL navigates market cycles within the Pharmaceuticals industry.

Evaluating the bottom line, Rafael Holdings Inc maintains a gross margin of 94.67%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -3988.11%, while the net margin is -3660.66%. These profitability ratios, combined with a Return on Equity (ROE) of -34.79%, provide a clear picture of how effectively RFL converts its operational activities into shareholder value.

In the context of the broader market, RFL competes directly with industry leaders such as MAMO and LPA. With a market capitalization of $54.27M, it holds a significant position in the sector. When comparing efficiency, RFL's gross margin of 94.67% stands against MAMO's 48.81% and LPA's 82.47%. Such benchmarking helps identify whether Rafael Holdings Inc is trading at a premium or discount relative to its financial performance.

Rafael Holdings has reported a net loss of $4.23 million for Q3 2026, with a 50% decline in revenue to $0.18 million compared to the previous year. The gross margin has fluctuated, but recent figures show a gross margin of 94.67% in Q4 2026, indicating some operational improvements. However, the overall financial health remains weak with a negative net income and declining revenues.